 |
IPA
Corporate Partners
… Partners
for better mental health for older people
To improve and advance the
mental health of older
people, IPA
recognizes that it needs the
full involvement and support
of the Psychogeriatrics
field, not only its
membership of academics,
clinicians, and researchers,
but also its colleagues in
the various
and diverse industries who
are concerned about the
wellbeing of
older adults.
|
In 2006, IPA
initiated a new approach to
industry support of IPA and the
field of
Psychogeriatrics through
creating a
special organizational
sponsorship program … IPA Corporate Partners.
Essentially, Corporate Partners
is a customized program where
IPA and the company design a set
of initiatives that meet our
common goals and priorities to
serve the field of
Psychogeriatrics and improve the
mental health of older people. This
unique relationship enables IPA
and industry to leverage their
collective expertise to:
• Advance IPA’s mission of
better mental health for older
people
• Collaborate as partners on
educational and research
projects that complement
industry and IPA common goals
and initiatives
• Educate the world about
Psychogeriatrics and best
practice
• Support and disseminate the
latest research in the field
• Foster innovation and new
approaches
• Communicate the importance of
geriatric mental health issues
to regulatory and government
agencies, governments and their
leaders worldwide |
IPA would like to extend an invitation to
our industry colleagues to be a part of our
professional
community as an IPA Corporate Partner.
Through our mutual commitment, IPA and
industry will
support the advancement of geriatric mental
health while acknowledging our unique roles
in this
initiative. This relationship will enable
IPA and industry to focus on longer-term
goals achieving
a mutual benefit and advancing mental health
for older people.
Corporate Partners can make a critical
difference to the scientific and clinical
practice of
Psychogeriatrics globally. For more
information about IPA or becoming an IPA Corporate
Partner,
contact
Susan
Oster, Executive Director.

IPA is an international, multidisciplinary
professional association committed to
improving geriatric
mental health throughout
the world. Founded in 1982, IPA has
approximately 1,100 members from
66
countries. For the IPA membership profile on
disciplines and region representation,
click here.
Welcome
to IPA’s first Corporate Partner
 |
“We are
delighted to be working closely
with the IPA to realize our
mutual missions of advancing the
science, mental health, and
well-being of aging persons
around the world.”
– Adrian Hobden
President of Myriad
Pharmaceuticals, Inc |
Myriad is a leading
biopharmaceutical company. Their
strategy is to develop novel
healthcare
products in areas of critical
need and to address some of the
most pervasive diseases of our
time. They offer a range of
cancer predictive medicine
products and are developing
therapeutics that
include drug candidates in the
areas of Alzheimer's disease and
cancer.
|
|